Anti-obesity drugs are only part of the larger treatment plan for most patients. Exercise and nutrition are also keys.

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

Viking Therapeutics has inked a $150m multi-year manufacturing deal with CordenPharma to secure the future supply of its ...

Compounded versions of popular drugs used for weight loss including Wegovy and Zepbound will soon no longer be available ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

I’ve introduced legislation in Florida to expand options for obesity treatment, including public health insurance coverage. | ...

Mishlawi said the current medicines were “only the beginning” because there are so many new obesity drugs ... according to the US Food and Drug Administration. When patents on weight loss ...

Most HHS workers were emailed an offer to leave their job for as much as $25,000 as part of President Trump’s government cuts ...